Background: the intravascular ultrasound (IVUS) is an invasive access technique that allows analysis of characteristics (qualitative and quantitative) of coronary atherosclerosis. Percutaneous coronary intervention (PCI) of complex lesions (i.e., American College of Cardiology/ American Heart Association class type C) remains challenging and the outcome may be compromised. The use of intravascular ultrasound (IVUS) to guide PCI was suggested to improve outcome. The Objectives: aim of this study was to compare intravascular ultrasound-guided and angiographyguided Intervention for Type C coronary lesions regarding major adverse cardiac events (MACE). Patients and Methods: Our study was conducted on patients undergoing elective PCI for type C coronary lesions in Cardiology Department in Ain Shams University hospitals. The study included 50 patients who underwent IVUS guidance PCI for Type C lesions and 50 patients who underwent only angiographic guidance PCI for Type C lesions. We evaluated the impact of IVUS guidance on clinical outcomes of patients undergoing PCI for complex lesions defined as ACC/AHA type C. Major adverse cardiovascular events (MACE), a composite end-point of all-cause mortality, Q-wave myocardial infarction and target lesion revascularization, were compared between the 2 groups. Mean follow-up duration was 12 months. Results: baseline clinical characteristics were similar in both patient groups. Adding IVUS to the procedure lengthened the procedure time. On the other hand, lower amount of radiographic contrast was required in the IVUS guided group during the procedure. Regarding the target coronary vessel in our study was similar in both groups with no significant difference. In addition, the number of ostial, proximal, mid and distal lesions was similar between the two studied groups. Patients with IVUS-guided PCI underwent more direct stenting, more postdilatation, larger maximal stent diameter and greater number of implanted stents. Consequently, the final diameter stenosis was significantly better in IVUS guided group. A strategy of routine IVUS for drug-eluting stent implantation in complex coronary lesions did not improve the 1-year MACE rates. Conclusion: use of intravascular ultrasound (IVUS) is associated with lower amount of radiographic contrast used during the procedure, more procedural time, more post dilatation and less postintervention final diameter stenosis. In addition, use of intravascular ultrasound (IVUS) in complex lesions allows proper assessment of minimal lumen area, optimizing PCI procedures and confirming stent well apposition.
INTRODUCTION
The intravascular ultrasound (IVUS) is an invasive access technique that allows the dynamic acquisition of tomographic imaging in vivo of the vascular lumen and wall, being considered one of the best invasive imaging methods for the analysis of characteristics (qualitative and quantitative) of coronary atherosclerosis 1 . In theory, the use of IVUS could improve the long-term results of angioplasty with stent implantation. These better results derive from at least three factors: the confirmation that there is no significant residual stenosis or that artery
Comparison of Immediate and Intermediate-Term Outcomes … 554 dissection did not occur; definite identification and removal of the calcified plaque that limits stent expansion; visualization of an optimal luminal gain 2 .
Percutaneous coronary intervention (PCI) remains challenging for high-risk patient groups, especially those with type C lesions, and their outcomes are often compromised 3-5 . It is further known that IVUS guidance of stent implantation may result in more effective stent expansion as compared to angiographic guidance alone 6 . Thus, it is plausible that IVUS guidance may improve short-and long-term outcomes of patients undergoing stent implantation. However, previous trials comparing IVUS guidance to angiographic guidance alone have provided conflicting results. Importantly, these studies have examined the results in unselected populations or have reported on predominantly noncomplex target lesions 7-9 . Thus, it can be argued that the impact of IVUS use on the outcome of patients with complex lesions in which the efficacy of IVUS-guided stent placement might be most effective has not been examined in detail. An American College of Cardiology/American Heart Association (ACC/AHA) classification was applied to differentiate between the complexities of the target lesions for PCI and to suggest that more complex lesions are associated with lower procedural success rates and poorer late outcomes. Class C lesions are considered to have the highest degree of lesion complexity 10 . Percutaneous coronary intervention (PCI) of complex lesions (i.e., American College of Cardiology/ American Heart Association class type C) remains challenging and the outcome may be compromised. The use of intravascular ultrasound (IVUS) to guide PCI was suggested to improve outcome 11 .
PATIENTS AND METHODS
The study was conducted on patients undergoing elective PCI for type C coronary lesions in Cardiology Department in Ain Shams University hospitals. The study included 50 patients who underwent IVUS guided PCI for Type C lesions and 50 patients who underwent only angiographic guided PCI for Type C lesions for a period of 1-year starting from August 2014. An American College of Cardiology/American Heart Association (ACC/AHA) classification was applied to differentiate between the complexities of the target lesions for PCI. Type C lesions included in the study were: diffuse (more than 2 cm length), excessive tortuosity of proximal segment, extremely angulated segments more than 90° and total occlusion more than 3 months old 10.
Inclusion criteria:
Patients referred for elective PCI of type C lesions for a period of 1 year. 
RESULTS

I-Baseline Clinical Characteristics
1) Demographics and clinical history
Baseline characteristics of the study population were similar between the 2 groups. The average age in the IVUS guided group is 56.74 years and in the angiography guided is 56.36 years.
Regarding the gender, 12 (24%) patients were female in the IVUS guided group and 38 (76%) were male while in the angiography guided group 13 (26%) patients were female and 37 (74%) were male (Figure 1 ,2).
The Clinical characteristics of the study population were similar between the 2 groups regarding coronary risk factors, history of heart disease and clinical presentation with no statistically significant difference between the two studied groups (Table 1 and The number of lesions treated was 73 lesions in the IVUS guided group and 71 lesions in the angiography guided group. Regarding the target coronary vessel, the number of lesions in left main coronary artery, left anterior descending coronary artery, left circumflex coronary artery and right coronary artery was similar in both groups with no significant difference.
2) Procedural details (Table 4,5)
The number of lesions treated was 73 lesions in the IVUS guided group and 71 lesions in the angiography guided group with an average 1.46 ± 0.79 per patient in the IVUS guided group and 1.42 ± 0.70 per patient in the angiography guided group. Regarding stent implantation, 84 stents were implanted in the IVUS group and 75 stents were implanted in the angiography guided group with an average 1.68 ± 0.87 per 557 patient in the IVUS guided group and 1.50 ± 0.76 per patient in the angiography guided group. Adding IVUS to the procedure lengthened the procedure time (37.40 ± 19.46 vs. 28.64 ± 10.71 min, P value= 0.006). On the other hand, lower amount of radiographic contrast was required in the IVUS guided group during the procedure (161.40 ± 53.11 vs 194.00 ± 94.03, P value= 0.035). Regarding stent Implantation, all the implanted stents (Sirolimus-eluting stent, Everolimuseluting stent, Biolimus-eluting stent, Zotarolimuseluting stent and Paclitaxel-eluting stent) are drug eluting stents CE approved. 41 Everolimuseluting stents were implanted in the IVUS guided group and only 18 Everolimus-eluting stents were implanted in the angiography guided group (48.81% vs 24.00%, P value= 0.002). 8 Biolimuseluting stents were implanted in the IVUS guided group while 20 Biolimus-eluting stents were implanted in the angiography guided group (9.52% vs 26.67%, P value= 0.009). The implantation of Sirolimus-eluting stent, Zotarolimus-eluting stent and Paclitaxel-eluting stent was similar in both groups with no significant difference. As regard stent diameter, there was no statistically significant difference between the IVUS group and the angiography guided group (3.11 ± 0.51 vs 2.99 ± 0.33, P value= 0.169). However, the total stent length was shorter in the IVUS group than in the angiography guided group (25.05 ± 7.82 vs 27.86 ± 6.20, P value= 0.049). As regard predilatation, there was no statistically significant difference between the IVUS group and the angiography guided group (56.16% vs. 59.15%), P value= 0.846). However, patients with IVUS-guided PCI underwent more postdilatation (90.41% vs. 47.89%, P value <0.001). Rotational atherectomy was not used in any patient, cutting balloon was used in only one patient in the IVUS guided group and Glycoprotein IIb/IIIa was used in one patient in each of the two studied groups.
On quantitative coronary angiography analysis, prediameter stenosis pre-intervention was similar in both groups but the final diameter stenosis post-intervention was less in the IVUS guided group (P value= 0.000). There was no statistically significant difference between the IVUS group and the angiography guided group regarding the angiographic success (100.0% vs. 95.77%, P =0.234). There were no significant differences between the two groups in the rates of dissection, abrupt closure and no reflow.
3) IVUS Analysis
IVUS analysis was done in the IVUS guided group using Atlantis S or I-Lab (Boston Scientific Corp./SCIMED, Minneapolis, Minnesota) in 36 patients (72%) and Eagle Eye (Volcano Therapeutics, Rancho Cordova, California) in 14 patients (28%). MLA, pre-intervention was 3.36 ± 1.63 mm2 and increased to 7.72 ± 2.92 mm2 post-intervention with stent well apposition confirmed in all patients (100%) ( Table 6 ).
III-Clinical Outcomes
In-hospital, 30-day and 12 month outcomes were similar between the 2 groups. There were no significant differences between the two groups in the rates of in hospital acute renal failure, bleeding, neurological events and the adverse cardiac events. Both primary and secondary end points were similar between the two studied groups with no statistically significant difference (Table.7 
DISCUSSION
The introduction of the drug-eluting stent (DES) has contributed to a significant reduction in in-stent restenosis and repeat revascularization. However, despite the use of the DES, percutaneous coronary intervention (PCI) of complex coronary lesions still remains challenging because the prevalence of in-stent restenosis and stent thrombosis. Intravascular ultrasound (IVUS) is an imaging modality often used as a supplement to coronary angiography and allows accurate assessment of the lumen, vessel wall, and 558 atherosclerotic plaque. IVUS has become indispensable in everyday clinical practice. Our study was conducted on patients undergoing elective PCI for type C coronary lesions in cardiology department in Ain Shams University hospitals. The study included 50 patients who underwent IVUS guidance PCI for Type C lesions and 50 patients who underwent only angiographic guidance PCI for Type C lesions. The IVUS or angiographic guidance was according to operator discretion. Baseline characteristics of the study population were similar between the 2 groups. Regarding the age and gender.
The Clinical characteristics of the study population were similar between the 2 groups regarding coronary risk factors, history of heart disease and clinical presentation with no statistically significant difference between the two studied groups. Adding IVUS to the procedure lengthened the procedure time (37.40 ± 19.46 vs. 28.64 ± 10.71 min, P value= 0.006). On the other hand, lower amount of radiographic contrast was required in the IVUS guided group during the procedure (161.40 ± 53.11 vs 194.00 ± 94.03, P value= 0.035). The use of lower amount of radiographic contrast in the IVUS guided group is due to its ability to accurately measure lumen, plaque, and vessel dimensions, thus IVUS might serve as an alternative tool to angiography in many steps during PCI. Optimization with ICUS to reduce stent restenosis study (OPTICUS study) was conducted between October 1996 and February 1998. a total of 550 patients were randomized (273 to ultrasound-guided stent implantation and 277 to angiography-guided stent implantation) at 26 centers. There were no differences between the 2 study groups with respect to baseline clinical and angiographic characteristics. In the ultrasound guided group, the number of balloons used and volume of contrast medium were higher, and fluoroscopy and total procedural time were longer 15 .
Regarding the target coronary vessel in our study, the number of lesions in left main coronary artery, left anterior descending coronary artery, left circumflex coronary artery and right coronary artery was similar in both groups with no significant difference. In addition, the number of ostial, proximal, mid and distal lesions was similar between the two studied groups.
All the implanted stents in our study are drug eluting stents CE approved. In our study, online IVUS analysis was done in the IVUS guide group. MLA, pre-intervention was 3.36 ± 1.63 mm2 and increased to 7.72 ± 2.92 mm2 post-intervention with stent well apposition confirmed in all patients (100%). A larger postprocedural minimal lumen diameter is believed to be a major contributing factor for the prevention of restenosis after DES implantation 17,18 .
In TULIP Study, online IVUS measurements at the end of the procedure showed an MLA of 6.0±3.3 mm2, with proximal and distal reference areas of 8.8±3.3 and 5.9±2.5 mm2, respectively; the MLD was 2.8±0.3 mm, with proximal and distal reference diameters of 3.3±0.4 and 2.7±0.4 mm, respectively. All criteria for optimal stent placement were achieved in 65 patients (89%). In the other 8 patients (10%), final in-stent MLA remained smaller than the distal reference lumen despite a balloon-to vessel ratio up to 1.3 and/or highpressure inflations.
We evaluated the impact of IVUS guidance on clinical outcomes of patients undergoing PCI for complex lesions defined as ACC/AHA type C. Major adverse cardiovascular events (MACE), a composite end-point of all-cause mortality, Q-wave myocardial infarction and target lesion revascularization, were compared between the 2 groups. In-hospital, 30-day and 12 month outcomes were similar between the 2 groups. There were no significant differences between the two groups in the rates of in hospital acute renal failure, bleeding, neurological events and the adverse cardiac events. Both primary and secondary end points were similar between the two studied groups with no statistically significant difference. In the study conducted by Wakabayashi et al., In-hospital and 30-day outcomes were similar between the 2 groups Importantly, post procedure MI, while high in both groups, was not affected by use of IVUS (12.5% vs. 13.5%, P = 0.57). Further, there were no significant differences between groups in the rates of in hospital acute renal failure, bleeding, and neurological events. Overall, the primary endpoint (1-year MACE) occurred in 169 patients (13.3%). The incidence was significantly less in patients who underwent IVUS-guided PCI as compared to those in whom the procedure was guided by angiography alone ( In OPTICUS study, Clinical follow-up was complete for 535 (98%) patients after 6 months and for 524 (95%) after 12 months. In-hospital clinical outcome did not show significant differences in either study group except for repeat percutaneous interventions which occurred in no patient assigned to ultrasoundguided stenting and in 6 (2.2%) patients assigned to angiography-guided stenting (P=0.030). The incidence of major adverse clinical events was not different in both groups. Jakabcin et al. conducted a study to assess the role of the intravascular ultrasound (IVUS) during implantation of Drug-eluting stents (DES) on long-term outcome in patients with complex coronary artery disease and high clinical risk profile with special attention to the development of late stent thrombosis (LST). Two hundred and ten patients were randomly assigned to receive DES either with (N = 105) or without (N = 105) the IVUS guidance. At the 18-month follow-up, there was no significant difference between both groups regarding MACE (11% vs. 12%; P = NS). Stent thrombosis has occurred in four patients (3.8%) in the group with and in 6 patients (5.7%; P = NS) in the group without the IVUS guidance. The trial has failed to demonstrate the superiority of routine IVUS guidance during DES implantation over standard high pressure . Regarding our study, a strategy of routine IVUS for drug-eluting stent implantation in complex coronary lesions did not improve the 1-year MACE rates. A randomized trial with a larger study population demonstrating the clinical usefulness of IVUS in complex coronary lesions intervention is required.
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